Clinically Proven LipoAvail® NAD Better Absorption

Overview

Effepharm

Liposomal technology encapsulates active ingredients within liposomes, mimicking intestinal cell membranes for improved absorption and efficacy.

LipoAvail® NAD+ offers the only clinically validated liposomal NAD+ on the market. Our clinical study shows that the LipoAvail® NAD+ group demonstrated 1.52 times higher NAD+ bioavailability compared to the regular NAD+ group. Meaning more NAD+ can be absorbed by your body for enhanced efficacy!

Download the Liposome White Paper to learn about industry trends; contact us for the study details and discover more clinically backed liposomal products.

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now

Related Topics

IngredientsHealth

Latest Content

Related Resources

The Global Regulatory Advantage Behind UTHEVER® NMN

The Global Regulatory Advantage Behind UTHEVER® NMN

Paid for by Effepharm Ltd

White Paper

Regulatory uncertainty remains one of the biggest challenges for NMN brands. Choosing the wrong ingredient could lead to compliance risks & market restrictions.

Discover UTHEVER® NMN’s Global Regulatory Landscape

Discover UTHEVER® NMN’s Global Regulatory Landscape

Paid for by Effepharm Ltd

White Paper

NMN has long faced regulatory challenges. Today, that landscape is changing. We consistently invest in scientific research & quality development, aiming to establish UTHEVER® as the world’s most compliant NMN ingredient brand.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.